Redeye comments on CombinedX’s Q3 report showing roughly flat organic growth and a solid rebound in ...
Redeye notes that AVTECH's reported figures aligned with its pre-announced results.
Redeye provides an initial comment on the Q3 2025 report from Sdiptech, where adjusted EBITA came in...
Redeye comments on Addnode’s Q3 report showing solid margins in PLM and PM.
Redeye comments on Sleep Cycle’s Q3 report, which was in line with expectations.
Redeye states that the Q3 report showed continued strong growth, especially in the Wireless segment.
Net sales and adj. EBIT were slightly below market consensus (LSEG) in Q3.
Redeye provides its initial take on Lifco’s Q3 2025 report, which aligned with our estimates.
Redeye returns with a more in-depth take on the Q3 report.
Redeye is again making some positive adjustments to our forecasts on the back of encouraging Q3 numb...
Atria's Q3 2025 was strong with a 3% top line and 7% adjusted EBIT beat against LSEG Data & Analytic...
While Fiskars' adjusted EBIT fell short of Modular Finance consensus, broad-based top-line growth is...
Redeye provides its initial take on MedCap’s Q3 2025 report, which came in broadly above our estimat...
Redeye retains its positive view of Teneo AI following a Q3 with soft q/q ARR growth but solid momen...
Hyresintäkterna steg med 45% till 15,5 meur och förvaltningsresultat ökade med 48% till 8,2 meur i d...
Redeye has a positive take on the news that Egetis has been granted a rolling NDA review based on cu...
Redeye comments on Invisio’s Q3-results which were in line with preliminary results announced on Oct...
* NOI -1% and rec PTP +2% vs ABGSCe * EC IFPM -3.4% q-o-q, partly due to cash position, ready for M&...
Redeye keeps its Base Case and retains a positive view of Vertiseit following the Q3 report.
* Q3 EBITDA NOK 14m vs ABGSCe NOK 9m * Awaiting stabilised markets * Only minor adjustments to estim...
